Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000257289, known as guanine nucleotide binding protein, alpha transducing 3 pseudogene, is a processed pseudogene located on chromosome 12[5]. Unlike protein-coding genes, pseudogenes do not result in functional proteins due to mutations or loss of coding potential[1][3][9]. This locus, derived from the GNAT3 gene, shows sequence similarity to the functional guanine nucleotide-binding protein subunit alpha transducing 3, but is inactive[1][3]. Pseudogenes may sometimes be transcribed and influence the expression of other genes through regulatory mechanisms such as acting as miRNA “decoys,” but there is no evidence of direct biological or disease-related function or druggability for this specific pseudogene[7][9]. This profile indicates that ENSG00000257289 is not appropriate as a therapeutic target and does not have the biological or pharmacological relevance required for targeted drug discovery or development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Guanine nucleotide binding protein, alpha transducing 3 pseudogene.